တၢ်အိၣ်ဆူၣ်အိၣ်ချ့ဒီးတၢ်အိၣ်မုာ်ဆိးပၢၤ
2026 Detailed Description of Preventive Services
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 821 - 830 လၢ 4744 အစၢတဖၣ်အကျါ
တၢ်ဆဲးလီၤမံၤ ဒီးတၢ်စူးကွံာ်ညိကွံာ်ခွဲးယာ်တဖၣ်
2025 Group Plan Enrollment/Waiver Form
တၢ်မၤကစၢ်အတၢ်တိစၢၤမၤစၢၤတဖၣ်
Small Group Employer Portal Request Form
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP14-25 MHCP Pharmacy Benefit Exclusion for Bizengri® and Opdivo Qvantig™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 12, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP15-25 Commercial Pharmacy Benefit Exclusion for Wezlana™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 12, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP16-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2025
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 12, 2025